GMP Violations At GSK's Former Puerto Rico Plant Are Basis Of $750 Million DoJ Settlement

In the first False Claims Act case alleging cGMP violations the government cites microbial contamination, split tablets and product mix-ups.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet